Literature DB >> 17187896

Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.

Katherine L Goldfeder1, Joshua M Levin, Kenneth A Katz, Loren E Clarke, Alison W Loren, William D James.   

Abstract

Ultraviolet (UV) reactivation reactions are rare and can occur in areas of prior sunburn or UV light therapy after the administration of chemotherapy, antibiotics, and other medications. Reactions may occur within days, as described after methotrexate therapy, or may appear months later, as described with ampicillin. Such reactions have been variably termed "UV recall," "sunburn recall," "photo recall," and "photodermatitis reactivation," making classification difficult. We report a UV reactivation reaction in a patient with acute lymphocytic leukemia treated with total body irradiation, etoposide, and methotrexate. We propose the terms "UV recall" and "UV enhancement" be used in future reports to classify UV reactivation reactions in a scheme analogous to the terminology for cutaneous reactions after radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187896     DOI: 10.1016/j.jaad.2006.11.009

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer.

Authors:  Frank I Scott; Ronac Mamtani; Colleen M Brensinger; Kevin Haynes; Zelma C Chiesa-Fuxench; Jie Zhang; Lang Chen; Fenglong Xie; Huifeng Yun; Mark T Osterman; Timothy Beukelman; David J Margolis; Jeffrey R Curtis; James D Lewis
Journal:  JAMA Dermatol       Date:  2016-02       Impact factor: 10.282

2.  Ultraviolet recall dermatitis reaction with sorafenib.

Authors:  Nicolas Magné; Cyrus Chargari; Pierre Auberdiac; Coralie Moncharmont; Yacine Merrouche; Jean-Philippe Spano
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

3.  [Methotrexate-associated photosensitization].

Authors:  K Hoffmann; F Casetti; C Schempp
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

4.  Severe Photo Toxicity Recalled by Docetaxel.

Authors:  Emma K Johansson; Britta Krynitz; Magnus Holmsten; Kerstin Klockhoff; Erika Isaksson Friman; Hanjing Xie
Journal:  Case Rep Oncol       Date:  2018-11-12

Review 5.  Anticancer treatments and photosensitivity.

Authors:  V Sibaud
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06       Impact factor: 9.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.